Absent myocardial I-123 BMIPP uptake in a family

Annals of Nuclear Medicine

Volumn 10, Issue 4, 1996, Pages 445-448

  Hwang, Eui Hyo ^a   Yamashfta, Akira ^a   Takemori, Hitoshi ^a   Taki, Junichi ^b   Nakajima, Kenichi ^b   Bunko, Hisashi ^b   Nakamura, Saburou ^a   Ikeda, Takayuki ^a   Tonami, Norihisa ^b  

^a Tsuruga City Hospital   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

hereditary abnormality; I 123 BMIPP; myocardial fatty acid metabolism

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; IODINE 123; THALLIUM 201;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; ELECTROCARDIOGRAPHY; FAMILIAL DISEASE; FATTY ACID METABOLISM; FEMALE; HEART MUSCLE METABOLISM; HEART SCINTISCANNING; HUMAN; HYPERTENSION; MALE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0030455201     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03164809     Document Type: Article

References (20)

1. Knapp FF Jr, Amburose KR, Goodman MM. New radioiodinated methyl-branched fatty acids for cardiac studies. Eur J Nucl Med 12: S39-44, 1986.
2. Tamaki N, Kawamoto M, Yonekura Y, Fujibayashi Y, Takahashi N, Konishi J, et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid. J Nucl Med 33: 659-667, 1992.
3. Saito T, Yasuda T, Gold HK, Leinbach R, Livini E, Elmaleh D, et al. Differentiation of regional perfusion and fatty acid uptake in zones of myocardial injury. Nucl Med Commun 12: 663-675, 1991.
4. Kurata C, Taniguchi T, Aoshima S, Kobayashi A, Yamazaki N, Kawa H, et al. Myocardial emission computed tomography with iodine-123-labeled beta methyl branched fatty acid in patients with hypertrophie cardiomyopathy. J Nucl Med 33: 6-13, 1992.
5. 201T1. Nucl Med Commun 14: 181-188, 1993.
6. Takeishi Y, Chiba J, Abe S, Tonooka I, Komatani A, Tomoike H. Heterogeneous myocardial distribution of iodine-123 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) in patients with hypertrophie cardiomyopathy. Eur J Nucl Med 19: 775-782, 1992.
7. 123I-beta-methyl-iodo-phenyl pentadecanoic acid. Eur J Nucl Med 21: 283-291, 1994.
8. Franken PR, Geeter FD, Dendale P, Demoor D, Block P, Bossuyt A. Abnormal free fatty acid uptake in subacute myocardial infraction after coronary thrombolysis: correlation with wall motion and inotropic reserve. J Nucl Med 35: 1758-1765, 1994.
9. Nakajima K, Shimizu K, Taki J, Uetani Y, Konishi S, Tonami N, et al. Utility of iodine-123-BMIPP in the diagnosis and follow-up of vasospastic angina. J Nucl Med 36: 1934-1940, 1995.
10. Taki J, Nakajima K, Matsunari I, Bunko H, Takada S, Tonami N. Impairment of regional fatty acid uptake in relation to wall motion and thallium-201 uptake in ischaemic but viable myocardium: assessment with iodine-123-labelled beta-methyl-branched fatty acid. Eur J Nucl Med 22: 1385-1392, 1995.
11. Matsunari I, Saga T, Taki J, Akashi Y, Mirai J, Wakasugi T, et al. Kinetics of iodine-123-BMIPP in patients with prior myocardial infarction: assessment with dynamic rest and stress images compared with stress thallium-201 SPECT. J Nucl Med 35: 1279-1285, 1994.
12. 123I)-iodophenylpentadecanoic acid, a myocardial imaging agent for evaluating fatty acid metabolism. KAKU IGAKU (Jpn J Nucl Med) 29: 305-317, 1992.
13. 123I)-iodophenyl-pentadecanoic acid, a myocardial imaging agent for evaluating fatty acid metabolism - a multi-center trial. KAKU IGAKU (Jpn J Nucl Med) 29: 413-433, 1992.
14. Fujibayashi Y, Yonekura Y, Takemura Y, Wada K, Matsumoto K, Tamaki N, et al. Myocardial accumulation of iodinated beta-methyl-branched fatty acid analogue, iodine-125-15-(p-iodophenyl)-3-R,S-methylpcntadecanoic acid (BMIPP), in relation to ATP content. J Nucl Med 31 : 1818-1822, 1990.
15. Fujibayashi Y, Yonekura Y, Kawai C, Yamamoto K, Tamaki N, Konishi J, et al. Basic studies on I-I23-beta-methyl-piodophenyl-pentadecanoic acid (BMIPP) for myocardial functional diagnosis: effect of beta-oxydation inhibitor. KAKU IGAKU (Jpn J Nucl Med) 25: 1131-1135, 1988.
16. Tamaki N, Kawamoto M, Yonekura Y, Fujibayashi Y, Magata Y, Torizuka T, et al. Assessment of fatty acid metabolism using 1-123 branched fatty acid: Comparison with positron emission tomography. Ann Nucl Med 7: SII41-SII47, 1993.
17. Opie LH. Metabolism of the heart in health and disease. Am Heart J 76: 685, 1968.
18. 123I-beta-methyl-iodophenyl-pentadecanoic acid myocardial scintigraphy in diabetic patients without overt ischemic heart disease. J Cardiol 26: 23-32, 1995.
19. Sorrentino D, Stump D, Potter DJ, Robinson RB, White R, Kiang CL, et al. Oleate uptake by cardiac myocytes is carrier mediated and involves a 40-kD plasma membrane fatty acid binding protein similar to that in liver, adipose tissue, and gut. J Clin Invest 82: 928-935, 1988.
20. Tanaka T, Kawamura K. Isolation of myocardial membrane long-chain fatty acid-binding protein: homology with a rat membrane protein implicated in the binding or transport of long-chain fatty acids. J Mol Cell Cardiol 27: 1613-1622, 1995.